Asolo Rep receives grant from Charles & Margery Barancik Foundation in support of the 2022-23 season
(SARASOTA, FLA) — Asolo Rep has received a $100,000 grant from Charles & Margery Barancik Foundation in support of the 2022-23 artistic season, the Access to the Arts program and the FSU/Asolo Conservatory London Study Program.
The gift will provide essential support for the 2022-23 mainstage season, which is an engaging mix of the classic and the new, bookended by the iconic musicals Cabaret and Man of La Mancha. The four-show repertory season of plays includes Ken Ludwig’s The Three Musketeers, Silent Sky, Chicken & Biscuits and Incident at Our Lady of Perpetual Help.
“We truly appreciate that Barancik Foundation recognizes the importance of Asolo Rep’s mission to serve the community not just by engaging and inspiring audiences through extraordinary theatrical experiences on stage, but also through enhanced public and educational programs that meet people where they are,” said Asolo Rep Managing Director Linda DiGabriele.
In addition to the artistic season, the support will also help subsidize the cost associated with the Education & Engagement Department’s Access to the Arts program. This includes Asolo Rep On Tour, a 45-minute production that visits schools and public locations in the community, and the Student Series, which makes mainstage performances accessible to students and offers curriculum and workshops developed for the classroom.
Finally, Barancik Foundation’s gift will bolster the FSU/Asolo Conservatory for Actor Training’s London Study Program, a culminating highlight of the MFA students’ three-year curriculum. This unique experience provides the graduating students with concentrated acting and voice classes from internationally regarded master teachers in the beautiful city of London.
“Chuck and Margie were huge fans of Asolo Rep, and it would warm their hearts to know that their foundation not only supported the exciting upcoming season, but was helping to reach into the schools in our area, providing access to Asolo Rep actors and performances to students,” said Teri A Hansen, foundation president and CEO. “Who knows how many budding actors those educational opportunities might help create?”
To learn more about Asolo Rep’s 2022-23 season and engagement programs, visit asolorep.org.
ABOUT ASOLO REP
Entering its 64th season, Asolo Repertory Theatre is recognized as one of the premier professional theatres in America and one of the largest in the Southeastern United States. One of the few select theatres in the nation that performs in true rotating repertory, Asolo Rep’s highly skilled acting company and extensive craftsmanship bring to life this unique performance method that gives audiences the opportunity to see multiple productions in the span of a few days. Asolo Rep presents up to 10 productions each season, including contemporary and classic works and provocative musical theatre experiences. A theatre district in and of itself, Asolo Rep is committed to expanding its reach into the community, furthering its collaboration with the best theatre artists working in the industry today and cultivating new artists through its affiliation with the FSU/Asolo Conservatory for Actor Training. Under the leadership of Producing Artistic Director Michael Donald Edwards and Managing Director Linda DiGabriele, Asolo Rep’s ambitious theatrical offerings and ground-breaking education and community programming engage audiences and ensure its lasting legacy for future generations. Visit asolorep.org to learn more.
ABOUT CHARLES & MARGERY BARANCIK FOUNDATION
The Charles and Margery Barancik family has long believed in the power of philanthropy to shape our world and enrich the lives of all people. It was the expression of this belief that led them in 2014 to establish Charles & Margery Barancik Foundation – a private, family foundation located in Sarasota, Florida. Barancik Foundation creates initiatives and awards grants in Sarasota and beyond in the areas of education, humanitarian causes, arts and culture, the environment and medical research. For more information, visit barancikfoundation.org.